| Literature DB >> 25909758 |
Ross D Hoehn1, David Nichols2, Hartmut Neven3, Sabre Kais4.
Abstract
G protein-coupled receptors (GPCRs) constitute a large family of receptor proteins that sense molecular signals on the exterior of a cell and activate signal transduction pathways within the cell. Modeling how an agonist activates such a receptor is fundamental for an understanding of a wide variety of physiological processes and it is of tremendous value for pharmacology and drug design. Inelastic electron tunneling spectroscopy (IETS) has been proposed as a model for the mechanism by which olfactory GPCRs are activated by a bound agonist. We apply this hyothesis to GPCRs within the mammalian nervous system using quantum chemical modeling. We found that non-endogenous agonists of the serotonin receptor share a particular IET spectral aspect both amongst each other and with the serotonin molecule: a peak whose intensity scales with the known agonist potencies. We propose an experiential validation of this model by utilizing lysergic acid dimethylamide (DAM-57), an ergot derivative, and its deuterated isotopologues; we also provide theoretical predictions for comparison to experiment. If validated our theory may provide new avenues for guided drug design and elevate methods of in silico potency/activity prediction.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25909758 PMCID: PMC4408984 DOI: 10.1038/srep09990
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1The tunneling spectrum of several known 5-HT2 agonists as well as the square of the tunneling PDF reflected below the energy axes; the square is used to highlight major spectral aspects.
The Spectral Similarity Index of each plot is given in the Supplemental Materials over several ranges and regions, noting that these similarity indices allude to good spectral agreement with the reference spectrum, LSD. More detailed information is provided within the Supplemental Material.
Figure 2(a) The tunneling spectra of several DOX class agonists as well as their molecular structures. (b) The inverse of the median effective concentration for the DOX class agonists plotted against the tunneling probability within the region at 1500 ± 35 cm−1. The trend of tunneling intensity follows roughly the trend of the agonist’s potency at the 5-HT2 receptor.
Figure 3(a) The tunneling spectra of several 2C-X class agonists as well as their molecular structures. (b) The inverse of the median effective concentration for the 2C-X class agonists plotted against the tunneling probability within the region at 1500 ± 35 cm−1. The trend of tunneling intensity follows roughly the trend of the agonist’s potency at the 5-HT2 receptor.